Thursday, November 29, 2012

【China AIDS:7579】 公共卫生治理电子期刊第一期 Health Governance Newsletter issue 1

各位朋友,

我们高兴地向大家宣布,经过长时间的准备,中国全球基金观察项目从即日起更名为公共卫生治理项目。公共卫生治理项目将一如既往地致力于公共卫生领域治理和透明度的相关工作,并衷心期望继续保持与诸位的合作。

附件是公共卫生治理电子期刊第一期中、英文版。

本期内容

一、 编者的话:排雷除荆,探寻输血感染艾滋病病毒赔偿的新路径

二、 政策建议:关于建立中国经血液感染艾滋病病毒者社会补偿机制的核心方案

顺祝冬暖!


Dear Friends,

We are pleased to announce that the China Global Fund Watch Initiative from now on upgrade as the Health Governance Initiative, and will focus on health related governance and transparency issues as always. It would be our honor to keep collaborations with you. Thank you for your support!Kindly have the Health Governance Newsletter issue 1 - Chinese and English version.

Content

Editor’s Note: Break a New Path through "Brambles and Thorns" to Compensate People Infected by HIV/AIDS Contaminated Blood

Policy Recommendations: Core Plan of the Establishment of Compensation Mechanism of People Infected by HIV/AIDS Contaminated Blood

With Best Regards!

--
公共卫生治理项目
电子邮件:gfwatch@gmail.com

Health Governance Initiative
Email:gfwatch@gmail.com



公共卫生治理项目是一个独立的、非盈利民间智库,主要致力于观察和研究中国公共卫生领域的治理和透明度,籍此促进公共参与和良好治理。

Health Governance Initiative is an independent not-for-profit civic think tank whose goal is to promote health related governance, transparency and civil society development in China, thus improve good governance and meaningful public participation.

--
◆新浪微博 @艾博公益艾滋病法律热线 (China AIBO AIDS Relief Law Hotline):
155 0113 7876 ――受艾滋病影响人群就业、就医和隐私权保护法律咨询专线
186 3922 8639 ――性工作者药物依赖者法律咨询专线
150 3718 6255――受艾滋病影响人群婚姻家庭和生命财产安全咨询专线
◆艾博公益艾滋病人治疗和心理互助热线:132 9832 7812
◆新浪微博: @艾博公益常坤
-~----------~----~----~----~-
"China AIDS Group中国艾滋病网络"
A:订阅,请发邮件到 chinaaidsgroup-subscribe@googlegroups.com
B:退订此论坛,请发邮件至 chinaaidsgroup-unsubscribe@googlegroups.com
C:既往内容汇总查询(需要翻墙):http://groups.google.com/group/chinaaidsgroup http://chinaaidsgroup.blogspot.com
D:Contact: Chang Kun 13349108944 changkun2010@gmail.com
★ 发送在本邮件组的所有内容信息,将被《青年与艾滋病》《社会工作与艾滋病》刊物自由采用,
★ 凡是挑�、��、非理性、�於情�性、胡�批�和�意�之言�,或是匿名人士之言�,以及所�表意�出�有不雅、粗鄙之文字等,本�件��不予以�示!
 
 

No comments:

Post a Comment